A multiproducer microbiome generates chemical diversity in the marine sponge Mycale hentscheli

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 117; no. 17; pp. 9508 - 9518
• Main Authors: Rust, Michael, Helfrich, Eric J. N., Freeman, Michael F., Nanudorn, Pakjira, Field, Christopher M., Rückert, Christian, Kündig, Tomas, Page, Michael J., Webb, Victoria L., Kalinowski, Jörn, Sunagawa, Shinichi, Piel, Jörn
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 28.04.2020
• Subjects: Bacteria; Bioactive compounds; Biological Sciences; Chemical defense; Dark matter; Drug development; Metabolites; Microbiomes; Microorganisms; Mycale hentscheli; Phylogeny; Physical Sciences; Poisons; Symbionts; Symbiosis; microbiomes; natural products; sponges; symbiosis; biosynthesis
• ISSN: 0027-8424; 1091-6490
• DOI: 10.1073/pnas.1919245117

Bacterial specialized metabolites are increasingly recognized as important factors in animal–microbiome interactions: for example, by providing the host with chemical defenses. Even in chemically rich animals, such compounds have been found to originate from individual members of more diverse microbiomes. Here, we identified a remarkable case of a moderately complex microbiome in the sponge host Mycale hentscheli in which multiple symbionts jointly generate chemical diversity. In addition to bacterial pathways for three distinct polyketide families comprisingmicrotubule-inhibiting peloruside drug candidates, mycalamide-type contact poisons, and the eukaryotic translation-inhibiting pateamines, we identified extensive biosynthetic potential distributed among a broad phylogenetic range of bacteria. Biochemical data on one of the orphan pathways suggest a previously unknown member of the rare polytheonamide-type cytotoxin family as its product. Other than supporting a scenario of cooperative symbiosis based on bacterial metabolites, the data provide a rationale for the chemical variability of M. hentscheli and could pave the way toward biotechnological peloruside production. Most bacterial lineages in the compositionally unusual sponge microbiome were not known to synthesize bioactive metabolites, supporting the concept that microbial dark matter harbors diverse producer taxa with as yet unrecognized drug discovery potential.